Immunocytochemistry of cytological specimens as a diagnostic and prognostic tool

M R Giovagnoli1, A Vecchione

  • 1Dipartimento di Medicina Sperimentale e Patologia, Cattedra di Citopatologia I, Universita' degli Studi di Roma, La Sapienza, Italy.

Anticancer Research
|July 1, 1996
PubMed

Insights

Immunocytochemistry, using monoclonal antibodies (MoAbs), is now routine in cytopathology labs. These antibodies aid in identifying and classifying tumors, complementing traditional methods for better diagnostic accuracy.

Area of Science:

  • Pathology
  • Immunology
  • Oncology

Background:

  • Immunocytochemistry has become a routine diagnostic tool in cytopathology over the last 20 years.
  • It complements traditional morphological studies for tumor identification and classification.

Purpose of the Study:

  • To review commonly used monoclonal antibodies (MoAbs) in diagnostic cytopathology.
  • To discuss their applications in identifying and classifying tumors.
  • To explore the feasibility of using MoAbs against markers of malignant transformation and tumor progression.

Main Methods:

  • Review of literature on monoclonal antibodies used in diagnostic cytopathology.
  • Discussion of applications of MoAbs in tumor identification and classification.
  • Evaluation of MoAbs targeting malignant transformation and progression markers.

Main Results:

  • Monoclonal antibodies (MoAbs) are frequently utilized in cytopathological laboratories.
  • Immunostaining with well-defined MoAbs enhances the accuracy of tumor identification and classification.
  • Availability of MoAbs against key biological markers facilitates their application in clinical settings.

Conclusions:

  • Immunocytochemistry with monoclonal antibodies is an essential component of modern diagnostic cytopathology.
  • MoAbs provide valuable data for tumor identification, classification, and understanding malignant progression.
  • Further application of MoAbs in clinical cytopathology is feasible and beneficial.